Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shang-nao Xie"'
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 9, Pp 3755-3759 (2023)
Objective: To study the feasibility, safety, and effectiveness of lateral thoracic adipofascial flaps in reconstructing the defects following breast-conserving surgery (BCS) in breasts with either no ptosis or mild ptosis. Methods: 37 female patients
Externí odkaz:
https://doaj.org/article/9e5cb567e75e4b4d8c7ac8d92153eccb
Autor:
Shang‐Nao Xie, Yuan‐Jie Cai, Bo Ma, Yanting Xu, Peng Qian, Juan‐Di Zhou, Fu‐Guang Zhao, Jie Chen
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2372-2379 (2019)
Abstract Fibroadenomas (FAs) are the most common fibroepithelial lesions and the most common benign tumors of the breast in women of reproductive age. Although MED12 mutations, an overwhelming majority of all mutations, and some other gene mutations
Externí odkaz:
https://doaj.org/article/76afbd1bc3394b4d9756b74be396f467
Publikováno v:
Asian Journal of Surgery.
Autor:
Yuan-Jie Cai, Bo Ma, Yanting Xu, Peng Qian, Jie Chen, Juan-Di Zhou, Shang-Nao Xie, Fu-Guang Zhao
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 5, Pp 2372-2379 (2019)
Cancer Medicine, Vol 8, Iss 5, Pp 2372-2379 (2019)
Fibroadenomas (FAs) are the most common fibroepithelial lesions and the most common benign tumors of the breast in women of reproductive age. Although MED12 mutations, an overwhelming majority of all mutations, and some other gene mutations have been
Autor:
Yuan-Jie Cai, Shang-Nao Xie, Juan-Di Zhou, Chun-Jing Xu, Jian Liu, Mei-Li Wang, Yi-Bo He, Lei Zheng, Xu Guo, Jie Chen, Fu-Guang Zhao, Yi Wang, Bo Ma
Publikováno v:
Oncology Letters
Nischarin is an integrin-binding protein, which is well known as a novel tumor suppressor. In breast cancer, Nischarin serves a critical role in breast cancer cell migration and invasion. However, the molecular mechanism underlying the role of Nischa
Publikováno v:
Molecular Medicine Reports
The present study aimed to investigate the expression of Nischarin protein in primary breast cancer (PBC), and to evaluate its role in tumor metastasis. Paired specimens of breast cancer tissues and adjacent normal tissues were surgically obtained fr
Autor:
Wei Wu Ye, Xiao Wen Ding, Yun Gao, Shang Nao Xie, Hong Jian Yang, Zhi Wen Pan, Xiao Jia Wang, Wen-Ming Cao
Publikováno v:
BMC Cancer
Background Germline mutations in the BRCA1 and BRCA2 genes greatly increase a woman’s risk of developing breast and/or ovarian cancer. The prevalence and distribution of such mutations differ across races/ethnicities. Several studies have investiga
Publikováno v:
Genetic Testing and Molecular Biomarkers. 16:689-694
Aims: We performed this retrospective study to evaluate the value of clinicopathological factors and a novel molecular marker stathmin in predicting treatment response to neoadjuvant chemotherapy (NCT) with docetaxel-containing regimens in patients w
Publikováno v:
Journal of Zhejiang University SCIENCE B. 12:575-581
A modified hemilaminectomy was introduced in an attempt to explore the operative techniques and the values of the limited approach to spinal cord tumors. Forty-five consecutive patients with intradural extramedullary lesions, who underwent modified h
Autor:
Hongchao Tang, Xianfeng Ding, Hongjian Yang, Xiaojia Wang, Yongfeng Li, Xuli Meng, Weimin Mao, Shang-Nao Xie
Publikováno v:
Amino acids. 48(2)
The gatekeeper T798M mutation in HER2 kinase domain has been observed to considerably shift drug sensitivity to HER2 in breast cancer therapy. Here, drug response of clinical tyrosine kinase inhibitors (TKIs) to the mutation was profiled using a synt